• Short Summary

    DEVELOPMENT OF A COPPER AND PLASTIC INTRAUTERINE CONTRACEPTIVE DEVICE WAS ANNOUNCED ON MONDAY (MARCH 22) BY G.

  • Description

    1.
    GV G.D. SEARLE & CO BUILDING.
    0.06

    2.
    SV INT WOMEN AT WORK (2 SHOTS)
    0.11

    3.
    SV CONTRACEPTIVES OUT OF MACHINE (2 SHOTS)
    0.18

    4.
    SU COMPANY OFFICIAL SPEAKS.
    1.52

    5.
    SV & SCU MEN WORKING IN LABORATORY.
    2.05


    SOUND TRANSCRIPT:



    SEQ. 4: COMPANY OFFICIAL: "THE CU7 IS A NEW TYPE OF INTRAUTERINE CONTRACEPTIVE DEVICE. THE STANDARD ICUDs AS THEY ARE CALLED, ARE MADE OF PLASTIC USUALLY. THEY CAN BE MADE OF OTHER THINGS AS WELL. AND THEY ARE INSERTED INTO THE UTERUS AND BY MECHANICAL MEANS PREVENT PREGNANCY. THE CU7 IS SUCH A DEVICE OF A NEW SHAPE AND IN ADDITION HAS WRAPPED ON ONE LIMB OF THE DEVICE A COIL OF COPPER WIRE. AND THIS COPPER WIRE RELEASES COPPER IONS AT A VERY SMALL RATE, MUCH LESS THAN YOU TAKE IN FOOD, FOR EXAMPLE, AND THIS COPPER INCREASES THE EFFICIENCY OF THE DEVICE CONSIDERABLY. SO THAT WE ARE ABLE TO USE A MUCH SMALLER DEVICE AND HAVE A HIGHER DEGREE OF EFFICACY."



    WOMAN REPORTER: "HOW EFFECTIVE IS THIS?"



    COMPANY OFFICIAL: "WELL THE FINAL FIGURES AREN'T IN YET BUT TO DATE IT SEEMS TO BE PRETTY CLOSE TO 100 PER CENT. WE DON'T HAVE THE ACTUAL FIGURES AS YET BUT IT'S VERY HIGH. IT APPROACHES THE EFFECTIVENESS OF THE PILL."



    WOMAN REPORTER: "AND HOW SAFE IS THIS FROM YOUR TESTING?"



    COMPANY OFFICIAL: "WE HAVEN'T HAD ANY DIFFICULTIES THAT AMOUNT TO ANYTHING. INTERUTERINE DEVICES IN GENERAL CAUSE SUCH THINGS AS CRAMPING, INTER-MENSTRUAL BLEEDING A LITTLE BIT. BECAUSE OF THE SMALL SIZE OF THE COPPER 7 THIS HAS BEEN HELD TO A MINIMUM, LESS THAN FIVE PER CENT OF WOMEN SEEM TO HAVE ANY REAL DIFFICULTY."




    Initials CO.18.04 TA/PN/CO/18.16



    Script is copyright Reuters Limited. All rights reserved

    Background: DEVELOPMENT OF A COPPER AND PLASTIC INTRAUTERINE CONTRACEPTIVE DEVICE WAS ANNOUNCED ON MONDAY (MARCH 22) BY G.C. SEARLE & Co., MANUFACTURES OF THE BIRTH CONTROL PILL ENOVID.

    THE DEVICE IS EXPECTED TO BE ON THE MARKET DURING THE NEXT FEW MONTHS AND WILL BE ISSUED ONLY BY PHYSICIANS. SO FAR, TESTS HAVE SHOWN THAT NO ADVERSE SIDE EFFECTS RESULT FROM USE OF THE DEVICE.

  • Tags

  • Data

    Film ID:
    VLVAE9P05M5G07WKIHOL3TZ919W8F
    Media URN:
    VLVAE9P05M5G07WKIHOL3TZ919W8F
    Group:
    Reuters - Source to be Verified
    Archive:
    Reuters
    Issue Date:
    24/03/1971
    Sound:
    Unknown
    HD Format:
    Available on request
    Stock:
    Colour
    Duration:
    00:02:04:00
    Time in/Out:
    /
    Canister:
    N/A

Comments (0)

We always welcome comments and more information about our films.
All posts are reactively checked. Libellous and abusive comments are forbidden.

Add your comment